Updated Jul 16, 2026
Todisco Joseph has filed 1 SEC Form 4 filing across 1 company in the last 90 days — selling. Lifetime open-market sales: $1.01M.
Joseph Todisco is the Chief Executive Officer and Director of CorMedix Inc., a biopharmaceutical company focused on developing therapeutic products for life-threatening diseases. He has been involved in the company through multiple SEC filings, indicating his active role in corporate governance.
| Role | Insider |
|---|---|
| Notability | 30/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-24 | TLPH | TALPHERA, INC. | A — Grant or award | 5.1K | $0.00 | |
| 2026-02-07 | CRMD | CorMedix Inc. | A — Grant or award | 77.2K | $0.00 | |
| 2026-01-28 | CRMD | CorMedix Inc. | F — Tax withholding / forfeiture | 27.3K | $7.27 | $199K |
| 2026-01-28 | CRMD | CorMedix Inc. | A — Grant or award | 225.9K | $0.00 | |
| 2026-01-20 | CRMD | CorMedix Inc. | F — Tax withholding / forfeiture | 22.7K | $6.78 | $154K |
| 2026-01-20 | CRMD | CorMedix Inc. | M — Option exercise | 29.6K | $3.38 | $100K |
| 2026-01-20 | CRMD | CorMedix Inc. | F — Tax withholding / forfeiture | 17.4K | $7.15 | $125K |
| 2025-12-20 | CRMD | CorMedix Inc. | S — Open-market sale | 30.0K | $12.00 | $360K |
| 2025-12-20 | CRMD | CorMedix Inc. | M — Option exercise | 30.0K | $4.43 | $133K |
| 2025-10-15 | TLPH | TALPHERA, INC. | A — Grant or award | 6.4K | $0.00 | |
| 2025-09-12 | CRMD | CorMedix Inc. | S — Open-market sale | 50.0K | $13.00 | $650K |
| 2025-09-12 | CRMD | CorMedix Inc. | M — Option exercise | 50.0K | $3.47 | $174K |
| 2025-05-10 | CRMD | CorMedix Inc. | F — Tax withholding / forfeiture | 21.2K | $11.66 | $247K |
Joseph Todisco is the Chief Executive Officer and Director of CorMedix Inc., a biopharmaceutical company focused on developing therapeutic products for life-threatening diseases. He has been involved in the company through multiple SEC filings, indicating his active role in corporate governance.…
1 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 0 open-market purchases () and 2 open-market sales ($1.01M) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Todisco Joseph profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.